Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06683352 · ClinicalTrials.gov registry record · Phase 1
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
A Phase 1 study, sponsored by BioNTech SE.
- Completed
- Registry status
- Phase 1
- Development phase
- 1,353
- Enrollment target
NCT06683352 is a Phase 1 study that has completed, run by BioNTech SE. The registered enrollment target is 1,353 participants.
The verdict
NCT06683352, a Phase 1 study, has completed, sponsored by BioNTech SE.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1,353 participants
- Enrollment target
Study Summary
This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will get one shot in each arm, either a flu or COVID vaccine, alone or mixed. The study lasts about 6 months, and participants need to visit the research site at least 3 times.
Interventions
- BIOLOGICAL COVID-19 Vaccine
- BIOLOGICAL Investigational Influenza Vaccine
- BIOLOGICAL Licensed Influenza Vaccine 1
- BIOLOGICAL Licensed Influenza Vaccine 2
- COMBINATION_PRODUCT Influenza and COVID Combination Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,353 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2025-07-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06683352
The ClinicalTrials.gov registry entry for NCT06683352 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1,353 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioNTech SE, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which COVID-19 Vaccine is the first listed.
NCT06683352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06683352 about?
NCT06683352 is a clinical study titled "A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People". This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will get one shot in each arm, either a flu or COVID vaccine, alone or mixed. The study lasts about 6 months, and participants need to visit the research s...
What is the current status of trial NCT06683352?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,353 participants. The study started on 2024-11-11. Estimated completion is 2025-07-15.
What interventions are being tested in trial NCT06683352?
The interventions under investigation include: COVID-19 Vaccine (BIOLOGICAL), Investigational Influenza Vaccine (BIOLOGICAL), Licensed Influenza Vaccine 1 (BIOLOGICAL), Licensed Influenza Vaccine 2 (BIOLOGICAL), Influenza and COVID Combination Vaccine (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06683352?
This trial is sponsored by BioNTech SE, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.